OCT 24, 2017 08:23 AM PDT

Discovering the Protein that Pushes T and B cells "Out of the Nest"

WRITTEN BY: Kara Marker

T cells and B cells, two immune system cell types you want on the prowl during an infection, need a molecular push to leave the circulation and enter the tissues to fight pathogenic invaders. What happens when the signals behind the molecular push are missing? Autoimmune disease, vascular damage, strokes, and more. In a new study from the National University of Singapore, researchers identify for the first time how this signal is produced.

Sphingosine-1-phosphate (S1P) is an extracellular chemical signal that travels in the blood vessels via blood cells, where it is released to manage various immune and vascular functions, like regulating the movement of T and B cells in the circulation. These immune cells are vital for successful immunity, but can also play a role in autoimmune disease.

Why is a lack of S1P signaling harmful? If T and B cells remained in the circulation during an infection in the body’s tissues, the host would be nearly defenseless against the attack. Additionally, abnormal or absent S1P signaling has vascular consequences, often contributing to heart disease and stroke.

The present study, published in Nature, marks the first time researchers completely understood the path taken by S1P while being produced in blood cells. Researchers involved in the study are very optimistic about the potential treatments for immune and vascular diseases to which the study’s findings could contribute.

Sphingosine-1-phosphate produced in erythrocytes and platelets is transported out of the cells into the blood by the Mfsd2b protein. Credit: Long N. Nguyen

 

The star of the show is a protein called “Major facilitator superfamily transporter 2b (Mfsd2b).” The new study demonstrated just how vital the protein is for blood cells to produce S1P. To get a clear picture how the role of Mfsd2b in S1P production, researchers observed mice who lacked the protein.

They saw that Mfsd2b-deficient mice had low S1P levels in the circulation, which ultimately lead to an “abnormally low” number of circulating immune cells and “increased sensitivity to shock,” a dangerous, life-threatening condition that occurs when the organs and tissues receive an inadequate amount of blood and oxygen.

They also saw that Mfsd2b-deficient mice had low red blood cells counts, a finding that was somewhat surprising. Mice were also abnormally sensitive to chemotherapy and radiotherapy, indicating an additional clinical application of the findings: treatment for cancer patients.

Study leader Long N. Nguyen says that his study “opens up new avenues of investigation aimed at regulating sphingosine-1-phosphate signalling for the treatment of various diseases.”



Sources: MedlinePlus.gov, National University of Singapore, Yong Loo Lin School of Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 03, 2018
Cell & Molecular Biology
OCT 03, 2018
Single Cell Modified in CAR T Therapy Causes Deadly Relapse
One cell meant a very different outcome for a patient that was the recipient of a cutting-edge cancer therapy....
OCT 09, 2018
Immunology
OCT 09, 2018
Allergen Labeling
Are the regulations for packaged foods strong enough? A recent investigation suggests allergens are not properly identified on food packaging...
NOV 14, 2018
Immunology
NOV 14, 2018
Stress in Youth Can Mean Depression as an Adult
A research team investigates early life stress and its relation to adult depression and anxiety...
NOV 28, 2018
Immunology
NOV 28, 2018
Regulators to the Rescue
Scientists at Scripps Research Institute describe the nature of an immune regulator protein...
DEC 05, 2018
Immunology
DEC 05, 2018
Combo-Kick to Battle Lymphoma
Combination immunotherapy has provided remission for patients suffering from Hodgkin's Lymphoma...
JAN 15, 2019
Immunology
JAN 15, 2019
A Possible Key to Severe Flu
By studying the impact that NPY and its receptor Y1R have on influenza in mice, the research group has now discovered that NPY produced in lung phagocytes can aggravate influenza....
Loading Comments...